Literature DB >> 24945696

Readmission penalties and health insurance expansions: a dispatch from Massachusetts.

Christopher Chen1, Gabriel Scheffler, Amitabh Chandra.   

Abstract

BACKGROUND: Payers are penalizing hospitals for high readmission rates. It is unknown whether major changes in population insurance coverage can affect readmission rates, despite the Affordable Care Act's coverage expansions coming into effect this year.
OBJECTIVE: To evaluate the impact of a large-scale insurance expansion on hospital readmissions, using Massachusetts' 2006 health reform as a natural experiment.
DESIGN: Difference-in-difference time-series design.
SETTING: All Massachusetts acute-care hospitals. PATIENTS: Inpatient visits from 2004 to 2010. MEASUREMENTS: Primary outcome was the hospital 30-day readmission rate. Readmissions to any Massachusetts hospital were tracked.
RESULTS: Decreases in uninsurance rates during and after reform were largely limited to the hospital quartile with the highest prereform uninsurance rates (from 14% uninsured at the start of the reform to 2.9% by the end of the study period). The other hospitals collectively experienced a smaller decline in their uninsured admissions (5.9% at the start of reform to 2.5% by the end of the study period). According to difference-in-difference regression analysis, the highest uninsured hospital quartile experienced a modest increase in their unadjusted readmission rate of 0.6 percentage points (95% confidence interval: 0.1%-1.1%) during the reform period as compared to the other hospital quartiles (P = 0.01). This represents a relative increase of 4.5% in the readmission rate. Risk-adjusted readmission rates showed no corresponding change.
CONCLUSIONS: The Affordable Care Act's insurance expansion may be associated with an increase in unadjusted readmission rates among hospitals that cared for disproportionate numbers of uninsured patients. Risk-adjustment appears to take this effect into account.
© 2014 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2014        PMID: 24945696     DOI: 10.1002/jhm.2213

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  6 in total

1.  Differences in Hospital Readmission Risk across All Payer Groups in South Carolina.

Authors:  Hrishikesh Chakraborty; Robert Neal Axon; Jordan Brittingham; Genevieve Ray Lyons; Laura Cole; Christine B Turley
Journal:  Health Serv Res       Date:  2016-09-28       Impact factor: 3.402

2.  The Affordable Care Act Medicaid Expansion Correlated With Increased Heart Transplant Listings in African-Americans But Not Hispanics or Caucasians.

Authors:  Khadijah Breathett; Larry A Allen; Laura Helmkamp; Kathryn Colborn; Stacie L Daugherty; Prateeti Khazanie; Richard Lindrooth; Pamela N Peterson
Journal:  JACC Heart Fail       Date:  2017-01-18       Impact factor: 12.035

3.  Comparison of Back-Propagation Neural Network, LACE Index and HOSPITAL Score in Predicting All-Cause Risk of 30-Day Readmission.

Authors:  Chaohsin Lin; Shuofen Hsu; Hsiao-Feng Lu; Li-Fei Pan; Yu-Hua Yan
Journal:  Risk Manag Healthc Policy       Date:  2021-09-14

4.  Predictive risk score for unplanned 30-day rehospitalizations in the French universal health care system based on a medico-administrative database.

Authors:  Vanessa Pauly; Hélène Mendizabal; Stéphanie Gentile; Pascal Auquier; Laurent Boyer
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

5.  Association between medication-related adverse events and non-elective readmission in acute ischemic stroke.

Authors:  James A G Crispo; Dylan P Thibault; Yannick Fortin; Daniel Krewski; Allison W Willis
Journal:  BMC Neurol       Date:  2018-11-19       Impact factor: 2.474

6.  Predicting 30-day hospital readmissions using artificial neural networks with medical code embedding.

Authors:  Wenshuo Liu; Cooper Stansbury; Karandeep Singh; Andrew M Ryan; Devraj Sukul; Elham Mahmoudi; Akbar Waljee; Ji Zhu; Brahmajee K Nallamothu
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.